Latest Breaking News On - Recent corporate - Page 19 : vimarsana.com

Trevena Reports Second Quarter 2023 Results and Provides Business Update

Trevena Reports Second Quarter 2023 Results and Provides Business Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesBob yoderCarrie bourdowNational institutes of healthDan ferrymanaging directorlifesci advisorsWake forest baptist healthJiangsu nhwa pharmaceutical coExchange commissionTrevena incCompany annual report on formCompany contactWake forest baptist health medical centerTrevena medical information contact centerBusiness officertrevena incJiangsu nhwa pharmaceuticalRecent corporate

Sonnet BioTherapeutics Provides Fiscal Year 2023 Third Quarter Business and Earnings Update

Sonnet BioTherapeutics Provides Fiscal Year 2023 Third Quarter Business and Earnings Update
tennesseedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tennesseedaily.com Daily Mail and Mail on Sunday newspapers.

United statesNew jerseyJack yauchRichard kenneyPankaj mohanJay crossDrug development summitSecurities exchangeSonnet biotherapeutics incAmerican association for cancer researchLife therapeutics pte ltdSonnet biotherapeutics holdings incExchange commissionSolebury strategic communicationsData safety monitoring boardAmerican association

Cellectar Reports Financial Results for Second Quarter 2023

FLORHAM PARK, N.J., Aug. 14, 2023 (GLOBE NEWSWIRE) Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage biopharmaceutical company focused on the.

United statesJarrod longcorMonique kosseJames carusoCellectar biosciencesCellectar biosciences incExchange commissionSociety of nuclear medicineDevelopment expenseTherapeutic area partnership oncologyRecent corporateNuclear medicineMolecular imaging annualTherapeutic area partnershipCash equivalentsAdministrative expense

Cellectar Biosciences: Cellectar Reports Financial Results for Second Quarter 2023 and Provides a Corporate Update

Cellectar Biosciences: Cellectar Reports Financial Results for Second Quarter 2023 and Provides a Corporate Update
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesJames carusoMonique kosseJarrod longcorCellectar biosciencesCellectar biosciences incDevelopment expenseSociety of nuclear medicineTherapeutic area partnership oncologyExchange commissionRecent corporateNuclear medicineMolecular imaging annualTherapeutic area partnershipCash equivalentsAdministrative expense

Aspira Women s Health® Reports Second Quarter 2023 Financial Results

Continued growth trend with second quarter revenue of $2.5 million, an increase of 23% over the second quarter of 2022.OvaSuiteSM volume of 6,289 .

United statesNew yorkMonique kosseWinfred parnellNicole sandfordTorsten hombeckGerard reillyConnecticut department of economicDrug administrationAspira women health incLifesci advisorsClinical researchAspira women healthAxia women healthCommunity developmentAmerican society of clinical oncology